Skip to main content

Or 34,00 After 66% tax deduction

I make a monthly donation I make an IFI donation
Un médecin

What is Clinical Research?

Clinical research refers to scientific studies carried out on human beings with the aim of furthering knowledge in biology or medicine. It focuses on improving knowledge about how the body works, diseases, developing new treatments or medical devices, and developing diagnostic methods to better manage patients.

Clinical Research Framework

Clinical Research Framework

Clinical research follows a specific study protocol and is conducted only under certain conditions:

  • Obtain consent from those involved in the research;
  • Obtain regulatory approvals and have taken all the necessary legal and ethical steps;
  • Be carried out by competent persons;
  • Take all measures to protect persons suitable for research;
  • Aim to increase biological and medical knowledge.

(Title II: Research involving the human person (Articles L1121-1 to L1128-12) – Legislation (legifrance.gouv.fr))
 

Three broad types of clinical research

Three broad types of clinical research

There are three main types of clinical research:

  • Non-interventional studies (e.g. cohort study, epidemiology, questionnaires, etc.): these studies improve knowledge about the human being, the disease and its evolution over time;
  • Experimental studies with minimal risks and constraints: these studies aim to advance biological and medical knowledge through, for example, brain imaging techniques (MRI, EEG, etc.) sometimes coupled with cognitive or behavioural tasks (tests of perception, memory, decision, etc.).
  • Interventional studies or clinical trials: these studies provide scientific evidence of the efficacy and safety of a new drug, device or management of a disease. This is the step necessary for a new molecule to become a drug or for a new medical device to be marketed.

News that might interest you

À la recherche de marqueurs d’imagerie dans la démence frontotemporale
Searching for Imaging Markers in Frontotemporal Dementia
Could exploring the relationships between different brain networks help us understand frontotemporal dementia (FTD)? This neurodegenerative disease, which progresses at varying rates, is often diagnosed late—when clinical signs are already severe. At...
01.07.2025 Research, science & health
Monocyte – un globule blanc qui se différencie en macrophage. Crédit : Université d’Edinbourg.
Discovery of a Macrophage Anomaly in Multiple Sclerosis
Certain patients with multiple sclerosis (MS) can partially regenerate myelin—the protective sheath that surrounds nerve fibers—which is damaged during the evolution of the disease. In studying how immune cells influence this remyelination...
12.19.2024 Research, science & health
Interneurones. Crédit : UCLA Broad Stem Cell Research Center.
Stimulating specific neurons in the striatum stops compulsive behaviour
What if we could resist compulsions? These irrational behaviours, particularly common in obsessive-compulsive disorder (OCD), are hard to suppress. At Paris Brain Institute, Éric Burguière's team shows that we can anticipate them and block them...
09.10.2024 Research, science & health
Les nerfs moteurs présents dans la moelle épinière se projettent vers la périphérie, où ils entrent en contact avec les muscles, formant des connexions appelées jonctions neuromusculaires. Crédit : James N. Sleigh.
Ultrasound show unexpected effects on motor neuron disease
Over the past fifteen years, neurosurgeons have been perfecting a fascinating technique: using ultrasound to temporarily open the blood-brain barrier to facilitate the action of therapeutic molecules in the central nervous system. At Paris Brain...
09.05.2024 Research, science & health
Un neurone
Rett syndrome: a new gene therapy on the way
Gene therapy could be our best chance of treating Rett syndrome, a neurological disorder that causes severe intellectual and motor impairments. At Paris Brain Institute, Françoise Piguet and her colleagues have looked closely at brain cholesterol...
07.16.2024 Research, science & health
Lésions d’un patient à l’inclusion dans le protocole (M0) disparues après 2 ans de traitement à la Leriglitazone (M24)
The dual effect of leriglitazone in X-linked Adrenoleukodystrophy (X-ALD)
In 2023, the team led by Professor Fanny Mochel (AP-HP, Sorbonne University), a Paris brain Institute researcher, showed that daily dose of leriglitazone slow down the progression of myelopathy in patients with X-linked adrenoleukodystrophy, and...
06.28.2024 Research, science & health
See all our news